Form 4: MicroVision CEO Sumit Sharma Granted 1.125 Million Restricted Stock Units

MicroVision, Inc. CEO and Director Sumit Sharma was granted 1,125,000 Restricted Stock Units (RSUs) on June 6, 2025, as reported in a recent SEC Form 4 filing.

Summary

• Sumit Sharma, the Chief Executive Officer and a Director of MicroVision, Inc. (MVIS), was the reporting person for this transaction.
• On June 6, 2025, Mr. Sharma was granted 1,125,000 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of MicroVision common stock.
• The granted RSUs are scheduled to vest in annual installments of 33% on each anniversary of the grant date, with full vesting expected by June 6, 2028.
• Vesting is contingent upon Mr. Sharma's continued employment with MicroVision on each vesting date.
• Following this transaction, Mr. Sharma beneficially owns 1,125,000 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: The grant of a significant number of Restricted Stock Units to the CEO is generally viewed as a positive for management alignment with long-term shareholder interests and executive retention, although it implies future potential dilution.

Positives

• The grant of a significant number of Restricted Stock Units (RSUs) to the CEO aligns management's long-term interests with those of shareholders by tying compensation to future stock performance.
• The multi-year vesting schedule (until June 2028) incentivizes the CEO's continued commitment and retention within the company.

Negatives

• The conversion of these RSUs into common stock upon vesting will result in dilution for existing shareholders, increasing the total number of outstanding shares.
• The grant itself does not represent an immediate cash inflow for the CEO or the company.

Risks

• The vesting of the Restricted Stock Units is subject to the CEO's continued employment with MicroVision; if employment ceases before full vesting, unvested units may be forfeited.

Future Outlook

The vesting schedule of the granted RSUs indicates a planned long-term commitment of the CEO to MicroVision, with full vesting extending until June 2028, contingent on continued employment.

Industry Context

The grant of Restricted Stock Units (RSUs) with a multi-year vesting schedule is a common and widely accepted practice in the technology and publicly traded company sectors. This form of equity compensation is frequently used to attract, retain, and incentivize key executives by aligning their financial interests with the long-term performance and shareholder value creation of the company.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential future dilution of existing shares upon the vesting and conversion of RSUs into common stock, but also benefit from enhanced management alignment with long-term company performance.
• Management (CEO): Receives a significant equity incentive that vests over several years, contingent on continued employment, providing a strong motivation for long-term value creation.

Next Steps

• The company will proceed with the annual vesting of the granted RSUs on June 6, 2026, June 6, 2027, and June 6, 2028, subject to the CEO's continued employment.
• Upon vesting, the RSUs will convert into shares of MicroVision common stock.

Key Dates

Recommendation

Keywords

MicroVision, MVIS, Sumit Sharma, Restricted Stock Units, RSU, SEC Form 4, Insider Grant, Equity Compensation, CEO Compensation, Executive Incentive